Literature DB >> 24155060

Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance.

Elena López-Camacho1, Rosa Gómez-Gil, Raquel Tobes, Marina Manrique, María Lorenzo, Beatriz Galván, Estefanía Salvarelli, Youssef Moatassim, Iñigo J Salanueva, Eduardo Pareja, Francisco M Codoñer, Miguel Alvarez-Tejado, María Pilar Garcillán-Barcia, Fernando De la Cruz, Jesús Mingorance.   

Abstract

OBJECTIVES: To characterize at the genomic level the evolution of multiresistance during an outbreak of Klebsiella pneumoniae in a burns intensive care unit. The outbreak involved a DHA-1 β-lactamase-producing strain that later acquired carbapenem and fosfomycin resistance, and in one case colistin resistance.
METHODS: The genomes of two isolates were sequenced and compared with a previously sequenced genome. The role of hypermutability was investigated by measuring the mutation frequencies of the isolates and comparison with a collection of control strains.
RESULTS: Sequence comparison identified four single-nucleotide variants and two transposon insertions. Analysis of the variants in the whole collection related carbapenem and fosfomycin resistance to a nonsense mutation in the ompK36 porin gene and colistin resistance to an IS1 insertion in the mgrB gene. The plasmid carrying the blaDHA-1 gene was unstable in the absence of antibiotics, and analysis of isolates that had lost the plasmid showed that the porin mutation alone was not sufficient to generate carbapenem resistance. The mutation frequencies were similar among all the strains analysed.
CONCLUSIONS: Carbapenem resistance required production of the DHA-1 β-lactamase and decreased permeability, but fosfomycin resistance depended only on permeability. Resistance to colistin might be related to an alteration in the regulation of the phoPQ system. Hypermutation is not related to the selection of porin mutants. Plasmid instability might be due to the high number of mobile elements and suggests a major role for antibiotic selection pressure in the emergence and evolution of this outbreak.

Entities:  

Keywords:  Klebsiella pneumoniae genome; antibiotic resistance; hypermutation; outbreak genomics

Mesh:

Substances:

Year:  2013        PMID: 24155060     DOI: 10.1093/jac/dkt419

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  34 in total

1.  MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.

Authors:  Antonio Cannatelli; Tommaso Giani; Marco Maria D'Andrea; Vincenzo Di Pilato; Fabio Arena; Viola Conte; Kyriaki Tryfinopoulou; Alkiviadis Vatopoulos; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

2.  Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France.

Authors:  Lucie Bardet; Sophie Baron; Thongpan Leangapichart; Liliane Okdah; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 3.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).

Authors:  Boudewijn L M de Jonge; James A Karlowsky; Krystyna M Kazmierczak; Douglas J Biedenbach; Daniel F Sahm; Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.

Authors:  Antonio Cannatelli; Vincenzo Di Pilato; Tommaso Giani; Fabio Arena; Simone Ambretti; Paolo Gaibani; Marco Maria D'Andrea; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

6.  Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Authors:  Tricia A Van Laar; Tsute Chen; Tao You; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 7.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

8.  Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae.

Authors:  Ching Hei Phoebe Cheung; Punyawee Dulyayangkul; Kate J Heesom; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

9.  Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.

Authors:  D van Duin; E D Cober; S S Richter; F Perez; M Cline; K S Kaye; R C Kalayjian; R A Salata; S R Evans; V G Fowler; R A Bonomo
Journal:  Clin Microbiol Infect       Date:  2014-12-12       Impact factor: 8.067

10.  Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.

Authors:  Qinglan Guo; Caressa Nicole Spychala; Christi Lee McElheny; Yohei Doi
Journal:  J Antimicrob Chemother       Date:  2016-01-07       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.